An Italian study published in Nature Medicine provides compelling evidence that fecal microbiota transplantation (FMT) can ...

Of the 20 patients in the lung cancer group, 80 per cent responded positively to immunotherapy after receiving fecal ...

Please provide your email address to receive an email when new articles are posted on . Fecal microbiota-based therapies are becoming more prevalent in the management of Clostridioides difficile ...

Adding fecal microbiota therapy to standard care for steroid-ineligible severe alcoholic-associated hepatitis appeared safe and effective in a small randomized trial from India. Survival at 90 days ...

SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

A newly identified metabolite in human feces improves immunotherapy and could radically change the treatment of lung cancer.

A therapy using fecal matter to combat a bad bug in the gut will now be regulated by the federal government, to the consternation of some physicians. The bug is Clostridium difficile, or C. diff, and ...

Clinical cure and no disease recurrence within 60 days without additional treatment was observed in 66.7% of 51 patients receiving FMT vs 61.2% of 49 patients receiving vancomycin. HealthDay News — ...

Swiss pharma giant Roche on Monday said it would buy Telavant, an immunology company developing a promising treatment for inflammatory bowel disease, in a deal worth more than $7 billion, as the ...